Private Wealth Management Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$295K Sell
1,170
-149
-11% -$32.1K 0.07% 87
2026
Q1
$287K Buy
1,319
+115
+10% +$25.5K 0.08% 72
2025
Q4
$275K Sell
1,204
-17
-1% -$3.87K 0.07% 75
2025
Q3
$283K Sell
1,221
-14
-1% -$2.85K 0.08% 71
2025
Q2
$229K Buy
1,235
+99
+9% +$18.4K 0.08% 76
2025
Q1
$238K Sell
1,136
-110
-9% -$21.4K 0.09% 73
2024
Q4
$221K Buy
1,246
+136
+12% +$25K 0.08% 76
2024
Q3
$219K Buy
1,110
+3
+0.3% +$560 0.09% 71
2024
Q2
$190K Sell
1,107
-24
-2% -$3.98K 0.08% 76
2024
Q1
$206K Sell
1,131
-34
-3% -$5.86K 0.09% 67
2023
Q4
$181K Buy
+1,165
New +$170K 0.09% 72

Other funds holding ABBV

Private Wealth Management Group's ABBV Position: Q2 2026 in Review

Private Wealth Management Group reduced its AbbVie (ABBV) stake by 11% in Q2 2026, selling an estimated $32.1K and leaving 1,170 shares worth $295K. The position accounts for 0.07% of the portfolio, ranked #87.

Private Wealth Management Group first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Private Wealth Management Group held 1,170 shares of AbbVie worth $295K as of Q2 2026.
  • Private Wealth Management Group sold 149 AbbVie shares in Q2 2026, an estimated $32.1K.
  • AbbVie made up 0.07% of Private Wealth Management Group's portfolio in Q2 2026, its #87 holding.
  • Private Wealth Management Group first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.